icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
17 Mar, 2021 15:25

Spain investigating woman’s death two weeks after dose of AstraZeneca Covid-19 vaccine

Spain investigating woman’s death two weeks after dose of AstraZeneca Covid-19 vaccine

Spanish health authorities say they are investigating the death of a 43-year-old woman who died on Tuesday after receiving her first dose of AstraZeneca vaccine, as well as two other cases of blood-clotting among recipients.

The woman, who lived in Marbella, was reportedly in good health before receiving the vaccine, but fell ill hours after her first dose on March 2. She twice visited emergency clinics over the following 10 days, before a CT scan showed a brain hemorrhage, according to local reports. She underwent surgery but died on Tuesday, and an autopsy will be carried out to determine the specific cause of her illness and death.

The government suspended Spain’s rollout of the Oxford/AstraZeneca Covid vaccine on Monday for two weeks while its regulators and the European Medicines Agency (EMA) investigate a fatality in each of Denmark and Austria, as well as reports of blood-clotting in a small number of people who had received the jab.

Also on rt.com EU announces Covid-19 vaccine passports plan to restart ‘free and safe movement’

The use of the AstraZeneca vaccine has been paused in 11 European countries as a precaution while awaiting the results of the various inquiries. The EMA said on Tuesday that it had full confidence in its continued use.

The Spanish Agency for Medicines and Health Products (AEMPS) said on Wednesday it is trying to find any “predisposing factor” that might lead to increased blood-clotting risks when the vaccine is given. It said these risks “can also occur in the general population,” and 1.9 million doses of the AstraZeneca inoculation had already been administered in Spain.

When its use was suspended in Spain, the jab had only been given to people aged between 18 and 55. So far, Spanish health authorities have administered almost 5.7 million doses combined of the AstraZeneca, Moderna and Pfizer vaccines.

If you like this story, share it with a friend!